Correlates of Specialty Substance Use Disorder Treatment Among Female Patients in the Veterans Health Administration

2012 ◽  
Vol 12 (3) ◽  
pp. 282-301 ◽  
Author(s):  
Elizabeth M. Oliva ◽  
Amy Gregor ◽  
Jerry Rogers ◽  
Aaron Dalton ◽  
Alex H. S. Harris ◽  
...  
2017 ◽  
Vol 27 (6) ◽  
pp. 639-645 ◽  
Author(s):  
Christine Timko ◽  
Katherine J. Hoggatt ◽  
Frances M. Wu ◽  
Amanda Tjemsland ◽  
Michael Cucciare ◽  
...  

2021 ◽  
Vol 2 (1) ◽  
Author(s):  
Allison M. Gustavson ◽  
Jennifer P. Wisdom ◽  
Marie E. Kenny ◽  
Hope A. Salameh ◽  
Princess E. Ackland ◽  
...  

Abstract Background Despite the risk of negative sequelae from opioid use disorder (OUD) and clinical guidelines for the use of effective medication treatment for OUD (M-OUD), many Veterans Health Administration (VHA) providers and facilities lag in providing M-OUD. An intensive external facilitation intervention may enhance uptake in low-adopting VHA facilities by engaging stakeholders from multiple clinical settings within a facility (e.g., mental health, primary care, pain specialty clinic, substance use disorder clinics). Our study identified pre-intervention determinants of implementation through qualitative interviews, described strategies employed during the first 6 months of intensive external facilitation, and explored patterns of implementation determinants in relation to early outcomes. Methods Guided by the integrated-Promoting Action on Research Implementation in Health Services (i-PARIHS) framework, we interviewed stakeholders at low-adopting VHA facilities prior to external facilitation, employed a rapid qualitative analytic process, presented findings during facility visits, and collaboratively created facilitation action plans to achieve goals set by the facilities that would increase M-OUD uptake. The primary outcome was the Substance Use Disorder (SUD)-16, which is a VHA facility-level performance metric consisting of the percent of patients receiving M-OUD among those with an OUD diagnosis. We examined the relationship between pre-implementation factors and 6-month SUD-16 outcomes. Results Across eight VHA facilities, we interviewed 68 participants. Implementation determinants included barriers and facilitators across innovation, context, and recipients constructs of i-PARIHS. Each facility selected goals based on the qualitative results. At 6 months, two facilities achieved most goals and two facilities demonstrated progress. The SUD-16 from baseline to 6 months significantly improved in two facilities (8.4% increase (95 % confidence interval [CI] 4.4–12.4) and 9.9% increase (95% CI 3.6–16.2), respectively). Six-month implementation outcomes showed that the extent to which M-OUD aligns with existing clinical practices and values was a primary factor at all facilities, with six of eight facilities perceiving it as both a barrier and facilitator. External health system barriers were most challenging for facilities with the smallest change in SUD-16. Conclusions Early impacts of a multi-faceted implementation approach demonstrated a strong signal for positively impacting M-OUD prescribing in low-adopting VHA facilities. This signal indicates that external facilitation can influence adoption of M-OUD at the facility level in the early implementation phase. These short-term wins experienced by stakeholders may encourage continued adoption and long-term sustainability M-OUD.


Sign in / Sign up

Export Citation Format

Share Document